John Myers - Rentokil Initial Managing Director

RKLIF Stock  USD 5.45  0.75  15.96%   

Managing Director

Mr. John Myers is Managing Director, North America of Rentokil Initial PLC. John joined Rentokil Initial in 2008 as President and Chief Executive of the Pest Control division in North America. Previously John served as Vice President of Business Development, Group VP, VP of Business Strategy and as Senior VP of Sales at Cintas Corporationrationration. Prior to that, he was President and Chief Executive at Bio Quest LLC. John has a diverse business background, with extensive sales, marketing and business strategy experience. He is a graduate of the University of Vermont where he earned a Bachelors degree in Business Administration. Additionally, he earned an MBA from Mercer University in Atlanta. since 2013.
Age 65
Tenure 11 years
Professional MarksMBA
Phone44 12 9385 8000
Webhttps://www.rentokil-initial.com

Rentokil Initial Management Efficiency

The company has return on total asset (ROA) of 0.0419 % which means that it generated a profit of $0.0419 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.2084 %, meaning that it generated $0.2084 on every $100 dollars invested by stockholders. Rentokil Initial's management efficiency ratios could be used to measure how well Rentokil Initial manages its routine affairs as well as how well it operates its assets and liabilities.
The company has accumulated 1.26 B in total debt with debt to equity ratio (D/E) of 2.64, implying the company greatly relies on financing operations through barrowing. Rentokil Initial Plc has a current ratio of 1.84, which is within standard range for the sector. Debt can assist Rentokil Initial until it has trouble settling it off, either with new capital or with free cash flow. So, Rentokil Initial's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Rentokil Initial Plc sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Rentokil to invest in growth at high rates of return. When we think about Rentokil Initial's use of debt, we should always consider it together with cash and equity.

Similar Executives

Found 1 records

MANAGING DIRECTOR Age

Karl WernerRB Global
59
Rentokil Initial plc, together with its subsidiaries, provides route-based services in North America, the United Kingdom, rest of Europe, Asia, the Pacific, and internationally. Rentokil Initial plc was founded in 1903 and is headquartered in Crawley, the United Kingdom. Rentokil Initial operates under Specialty Business Services classification in the United States and is traded on OTC Exchange. It employs 46000 people. Rentokil Initial Plc [RKLIF] is a Pink Sheet which is traded between brokers as part of OTC trading.

Management Performance

Rentokil Initial Plc Leadership Team

Elected by the shareholders, the Rentokil Initial's board of directors comprises two types of representatives: Rentokil Initial inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Rentokil. The board's role is to monitor Rentokil Initial's management team and ensure that shareholders' interests are well served. Rentokil Initial's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Rentokil Initial's outside directors are responsible for providing unbiased perspectives on the board's policies.
Stewart Power, Chief Marketing Officer
Alain Moffroid, Managing Director, Pacific
Julie Southern, Non-Executive Director
Richard Solomons, Non-Executive Director
Mark Purcell, Chief Officer
Vanessa Evans, Group Human Resources Director
Alan Giles, Independent Non-Executive Director
Phill Wood, Managing Director
Martin Sawkins, Group HR Director
Angela SeymourJackson, Non-Executive Director
Crispin Davis, Non-Executive Director
Malcolm Padley, Director Communications
Linda Yueh, Non-Executive Director
Gary Booker, Chief Marketing, Innovation and Strategy Officer
Daragh Fagan, Group General Counsel, Company Secretary and Member of Investment Committee
John Pettigrew, Non-Executive Director
Katharine Rycroft, Head of Investor Relations
Jurgen Hofling, Managing Director, Europe
Peter Bamford, Independent Non-Executive Director
Andrew Ransom, CEO, Executive Director and Chairman of Investment Committee
Jeremy Townsend, CFO, CIO, Executive Director, Chairman of Disclosure Committee, Chairman of Group Risk Committee and Member of Investment Committee
Christopher Geoghegan, Non-Executive Director
Andy Ransom, CEO, Executive Director
Stuart IngallTombs, CFO Director
John McAdam, Non-Executive Chairman of the Board
John Myers, Managing Director
Paul Cochrane, Managing Director, Asia
Rachel Canham, Group Counsel
Richard Burrows, Independent Non-Executive Director

Rentokil Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Rentokil Initial a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Currently Active Assets on Macroaxis

When determining whether Rentokil Initial Plc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Rentokil Initial's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Rentokil Initial Plc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Rentokil Initial Plc Stock:
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Rentokil Initial Plc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product.
You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.

Complementary Tools for Rentokil Pink Sheet analysis

When running Rentokil Initial's price analysis, check to measure Rentokil Initial's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Rentokil Initial is operating at the current time. Most of Rentokil Initial's value examination focuses on studying past and present price action to predict the probability of Rentokil Initial's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Rentokil Initial's price. Additionally, you may evaluate how the addition of Rentokil Initial to your portfolios can decrease your overall portfolio volatility.
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Please note, there is a significant difference between Rentokil Initial's value and its price as these two are different measures arrived at by different means. Investors typically determine if Rentokil Initial is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Rentokil Initial's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.